Donal P. McLornan

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (9)

Richard Dillon

King's College

UNITED KINGDOM

View details

Vikas Gupta

CANADA

View details

Srdan Verstovsek

UNITED STATES

View details

Sergio Giralt

Chief Attending, Adult BMT Service

Memorial Sloan Kettering Cancer Center

UNITED STATES

View details

Ibrahim Yakoub-Agha

Professeur des Universités - Praticien Hospitalier

Centre Hospitalier Régional Universitaire de Lille

FRANCE

View details

Juan Carlos Hernandez-Boluda

University of Valencia

SPAIN

View details

Patrick Hayden

Trinity College Dublin School of Medicine

IRELAND

View details

Muhammad Bilal Abid

UNITED STATES

View details

Grzegorz Helbig

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Donal P. McLornan

Research Interests

Explore related searches

Contact this professor

Articles (11)

Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy

Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the <scp>EBMT</scp>

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis

Differential inhibition of T cell receptor and STAT5 signalling pathways determines the immunomodulatory effects of dasatinib in chronic phase chronic myeloid leukemia.

Advanced Systemic Mastocytosis with associated haematological neoplasm: Treatment with avapritinib can facilitate successful bridge to allogeneic haematopoietic cell transplant

Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib.

Updates on accelerated and blast phase myeloproliferative neoplasms: Are we making progress?

Correction: An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT.

Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey

An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT.

Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience.

Collaborators (9)

Richard Dillon

Vikas Gupta

Srdan Verstovsek

Sergio Giralt

Ibrahim Yakoub-Agha

Juan Carlos Hernandez-Boluda

Patrick Hayden

Muhammad Bilal Abid

Grzegorz Helbig

Make your next move.